Literature DB >> 6885113

The localization of the binding site(s) on human IgG1 for the Fc receptors on homologous monocytes and heterologous mouse macrophages.

A Ratcliffe, D R Stanworth.   

Abstract

Two different methods, a rosette assay and a direct binding assay, have been employed in an examination of the binding of human IgG1 to mouse macrophages. In both cases, inhibition of IgG binding was demonstrated by Fc (CH2 + CH3 domains) and pFc' (CH3 domains) fragments of human IgG. In a homologous system, the binding of 125I-human IgG to human peripheral-blood monocytes was inhibited by the Fc fragment whereas the pFc' fragment was inactive. Scatchard plot analysis of the binding data from both the heterologous and homologous systems allowed association constants and numbers of receptors per cell to be calculated. A more thorough examination of the possible location of IgG Fc-receptor binding sites was made using less orthodox proteolytic cleavage fragments of IgG. The site on human IgG1 responsible for binding to mouse macrophage Fc receptors was confirmed to be within the CH3 domains. Human IgG1 binding to homologous monocytes was shown, using a dimeric C gamma 2 domain fragment, to be via the CH2 domains, and was dependent on the integrity of the covalent interaction between the C gamma 2 domains at the hinge region.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885113      PMCID: PMC1454235     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Localization of the IgG effector site for monocyte receptors.

Authors:  F Ciccimarra; F S Rosen; E Merler
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  Investigation of the binding site of mouse IgG subclasses to homologous peritoneal macrophages.

Authors:  S Dissanayake; F C Hay
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

3.  Cytophilic activity of IgG2 from sera of unimmunized guinea-pigs.

Authors:  R G Leslie; S Cohen
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

4.  Subfragments from the Fc fragment of human immunoglobulin G. Isolation and physicochemical charaterization.

Authors:  M W Turner; H Bennich
Journal:  Biochem J       Date:  1968-03       Impact factor: 3.857

5.  Evidence for the domain hypothesis: location of the site of cytophilic activity toward guinea pig macrophages in the C H 3 homology region of human immunoglobulin G.

Authors:  D Yasmeen; J R Ellerson; K J Dorrington; R H Painter
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

6.  Localisation of monocyte binding site of human immunoglobulin G.

Authors:  G O Okafor; M W Turner; F C Hay
Journal:  Nature       Date:  1974-03-15       Impact factor: 49.962

7.  Characterisation of a new tryptic sub-fragment of human and rabbit IgG Fc fragment.

Authors:  N Matthews; G Stewart; D R Stanworth
Journal:  Immunochemistry       Date:  1971-10

8.  The covalent structure of an entire gammaG immunoglobulin molecule.

Authors:  G M Edelman; B A Cunningham; W E Gall; P D Gottlieb; U Rutishauser; M J Waxdal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-05       Impact factor: 11.205

9.  The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cgamma2 and Cgamma3 homology regions of human immunoglobulin G1.

Authors:  D Yasmeen; J R Ellerson; K J Dorrington; R H Painter
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

10.  Properties of antibodies cytophilic for macrophages.

Authors:  A Berken; B Benacerraf
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  7 in total

1.  Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies.

Authors:  M S Chappel; D E Isenman; M Everett; Y Y Xu; K J Dorrington; M H Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

2.  Rapid clearance of the lupus antigen Sm is delayed by autoantibody: a possible mechanism of autoimmunity perpetuation.

Authors:  M Field; R D Melsom; F M Brennan; D G Williams; L Schreiber; D A McCarthy; R N Maini; R D Nelsom
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation.

Authors:  Rajnish Kumar; Michael Tuen; Hualin Li; Doris B Tse; Catarina E Hioe
Journal:  Vaccine       Date:  2011-09-23       Impact factor: 3.641

4.  MRL mice show an age-related impairment of IgG aggregate removal from the circulation.

Authors:  M Field; F M Brennan; R D Melsom; D McCarthy; P Mumford; R N Maini
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

5.  Targeting a Neutralizing Epitope of HIV Envelope Gp120 by Immune Complex Vaccine.

Authors:  Rajnish Kumar; Maria Luisa Visciano; Hualin Li; Catarina Hioe
Journal:  J AIDS Clin Res       Date:  2012-03-09

6.  The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120.

Authors:  Catarina E Hioe; Maria Luisa Visciano; Rajnish Kumar; Jianping Liu; Ethan A Mack; Rachel E Simon; David N Levy; Michael Tuen
Journal:  Vaccine       Date:  2009-10-29       Impact factor: 3.641

7.  Matrilysin (Matrix Metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (alpha(E)beta(7)-integrin).

Authors:  Anne M Manicone; Isham Huizar; John K McGuire
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.